Concepedia

Yi Kong

YK

Statistics

Publications

54

Citations

1.5K

H-Index

22

Active since

2002

Affiliations

China Pharmaceutical University(Current)

Hunan Cancer Hospital

Central South University

University of North Carolina at Chapel Hill

Chinese Academy of Sciences

Yi Kong is an author at China Pharmaceutical University specializing in medicine, pharmacology, and biochemistry.

ORCID

Top concepts

Publications per year

2002–2025

54

Publications

54

CircRNA-5692 inhibits the progression of hepatocellular carcinoma by sponging miR-328-5p to enhance DAB2IP expression

Zhenguo Liu, Yaqun Yu, Zebing Huang et al. · Cell Death and Disease · 2019 · 227 citations · Full text

The chemical and digestive properties of a soluble glucan from Agrobacterium sp. ZX09

Aihui Xiu, Yi Kong, Mengyi Zhou et al. · Carbohydrate Polymers · 2010 · 92 citations

, , +12

Two novel antimicrobial peptides from centipede venoms

Kanfu Peng, Yi Kong, Lei Zhai et al. · Toxicon · 2009 · 76 citations

, , +4

RGD-Modified Albumin Nanoconjugates for Targeted Delivery of a Porphyrin Photosensitizer

Fang Li, Yan Zhao, Chengqiong Mao et al. · Molecular Pharmaceutics · 2017 · 57 citations · Full text

, , +20

Purification and characterization of a novel antithrombotic peptide from Scolopendra subspinipes mutilans

Yi Kong, Shilong Huang, Shuai Li et al. · Journal of Ethnopharmacology · 2012 · 51 citations

, , +6

1–5 of 54